<!--
Copyright 2020 Google LLC.

This work is licensed under the Creative Commons Attribution 4.0
International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/ or send a letter
to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA.
-->
<model>
  <name>FemDophilus</name>
  <author>
    <name>Google</name>
    <email>scanned-objects@google.com</email>
  </author>
  <version>1.0</version>
  <sdf version="1.6">model.sdf</sdf>
  <description>Fem-Dophilus
Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1  and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor  Reid and Dr. Andrew Bruce at  Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract.* Clinical trials have shown that GR-1 and RC-14: Help to maintain or restore healthy vaginal  flora that are important in maintaining  vaginal health.* Support the health of the urinary tract.* Fem-dophilus is manufactured under pharmaceutical GMP conditions insuring potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.</description>
</model>
